INDIVIDUALIZATION OF PHENYTOIN DOSAGE REGIMENS

被引：0

作者：

LUDDEN, TM

ALLEN, JP

VALUTSKY, WA

VICUNA, AV

NAPPI, JM

HOFFMAN, SF

WALLACE, JE

LALKA, D

MCNAY, JL

机构：

[1] UNIV TEXAS,HLTH SCI CTR,DEPT PHARMACOL,SAN ANTONIO,TX 78284

[2] UNIV TEXAS,COLL PHARM,DEPT PHARM,ARLINGTON,TX 76010

[3] UNIV TEXAS,HLTH SCI CTR,DEPT MED,SAN ANTONIO,TX 78284

[4] UNIV TEXAS,HLTH SCI CTR,DEPT PATHOL,SAN ANTONIO,TX 78284

[5] AUDIE MURPHY VET ADM HOSP,SAN ANTONIO,TX

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1977年 / 21卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：287 / 293

页数：7

共 50 条

[1] INDIVIDUALIZATION OF DRUG-DOSAGE REGIMENS
PLATT, DR
CLINICS IN LABORATORY MEDICINE, 1987, 7 (02) : 289 - 299
[2] OPTIMUM PHENYTOIN-DOSAGE REGIMENS
LUDDEN, TM
HAWKINS, DW
ALLEN, JP
HOFFMAN, SF
LANCET, 1976, 1 (7954) : 307 - 308
[3] PHENYTOIN DOSAGE INDIVIDUALIZATION - 5 METHODS COMPARED IN THE ELDERLY
HUDSON, SA
FARQUHAR, DL
THOMPSON, D
SMITH, RG
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1990, 15 (01) : 25 - 34
[4] INDIVIDUALIZATION OF DIGOXIN DOSAGE REGIMENS BASED ON THE PHARMACOKINETIC SIMULATION
HAYASHI, R
SHIRAI, J
TAKANO, T
NISHIMOTO, Y
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1982, 46 (08): : 838 - 839
[5] RAPID INDIVIDUALIZATION OF GENTAMICIN DOSAGE REGIMENS IN 66 BURN PATIENTS
ZASKE, DE
CIPOLLE, RJ
SOLEM, LD
STRATE, RJ
BURNS, 1981, 7 (03) : 215 - 220
[6] INDIVIDUALIZING PHENYTOIN DOSAGE REGIMENS USING A PROGRAMMABLE CALCULATOR
NG, PK
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1980, 37 (04): : 529 - 533
[7] CONTRIBUTION OF SERUM LEVEL MONITORING IN THE INDIVIDUALIZATION OF CARBAMAZEPINE DOSAGE REGIMENS
GONZALEZ, ACA
SANCHEZ, MJG
HURLE, AD
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1988, 26 (08) : 409 - 412
[8] INDIVIDUALIZATION OF PHENYTOIN THERAPY
ADEBIMPE, VR
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 236 (26): : 2943 - 2943
[9] INDIVIDUALIZATION OF PHENYTOIN THERAPY
LUDDEN, TM
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1980, 32 (02) : 152 - 152
[10] PHENYTOIN DOSAGE
KAUL, AF
KING, W
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1981, 15 (03): : 215 - 215

← 1 2 3 4 5 →